scholarly journals Precaution & Safety Methods for Hospital Duty During covid-19 Pandemic Era for Healthcare Workers of Bihar, India: A protective & Supportive Approach

2021 ◽  
Author(s):  
Piyush Kumar

The current ongoing coronavirus pandemic caused by SARS-CoV-2/covid-19/novel coronavirus is an acute infectious communicable disease spreading mainly via respiratory, eye, mouth and other possible routes from person to person as well as through contact with infected non living objects. Added to previous global burden of NCDs (non communicable diseases) & other communicable diseases this new pandemic burden of covid-19 pandemic have put a stress on already overstressed health system of India particularly poor states like Bihar. The delivery of health services is of utmost importance and prime concern in India particularly poor states like Bihar due to high population load with limited resources, poor infrastructure and huge demand on healthcare system. The Healthcare workers (HCWs) are particularly vulnerable group hence this topic needs essential attention and protection. The SARS-CoV-2 pandemic had presented a challenge even for developed healthcare systems around the world. A sense of fear gripped the whole world due to pandemic and India is not an exception. The scarce healthcare resources including manpower, infrastructure, transportation (ambulance services) etc. have been largely deployed to tackle the situation of pandemic of Covid-19. This shift & covid-19 pandemic has tremendous and detrimental effects on HCWs. The healthcare workers of India as well as Bihar are getting frequently infected leading to death of thousands of healthcare workers till date. Although there are several guidelines issued for precaution and safety at workplace by WHO (world Health Organization) & several accredited organizations but a protective and supportive approach from local management and governance is need of the hour. It seems that there is failure of protective and preventive measures at workplace documented and evidenced by several deaths of healthcare workers. Consequently it is apparent from above scenario to ensure the health and safety of healthcare workers in order to control the outbreak and decrease panic and fear among healthcare workers. In this article I am sharing methods and various ways for protecting healthcare workers (HCWs) while having hospital duties as well as policy makers and management people can also find this article useful while making policies for protecting and safeguarding HCWs. This article aims to reduce incidence/prevalence as well as mortality and morbidity of HCWs in Bihar by suggesting important precautions, preventive measures and other facts to be adopted by healthcare workers at workplace as well as drawing attention of policy maker, important stakeholders and management people to provide protection to HCWs.

Author(s):  
Abdul Ghafar Sherzad ◽  
Yan Tu ◽  
Weitao Liu ◽  
M. Azim Azimee ◽  
Nemat Arash ◽  
...  

The novel coronavirus, or COVID-19, emerged from Wuhan, Hubei Province, China, and has recently spread all over the world. During the COVID-19 pandemic, healthcare workers struggle against this microscopic enemy due to their job responsibilities, thus leading to be infected in some of them, even some of them are died in line of duty. As of 2 February 2021, 37 million cases of COVID-19 among health workers from 183 countries and regions were reported to the World Health Organization (WHO), a figure that represents 36% of the total cases globally. The median age of these cases was 42 years and 68% were women. On May 24, 2021, the World Health Organization (WHO) stated that at least 115,000 healthcare workers have died due to COVID-19 worldwide since the pandemic began last year.  It is important to pay attention to the situation related to COVID-19 infection for medical staff and their preventive measures. This paper reviews the literature on all available information about the situation and preventive measures (The primary prevention of COVID-19 is to break the chain of transmission from infected to healthy people, secondary preventive measures comprise the use of health screening and recognition activities to ascertain those infected with COVID-19 and tertiary prevention consists of treatment and proper rehabilitation) related to COVID-19 infection for medical staff.


2020 ◽  
Vol 8 ◽  
Author(s):  
Bapi Gorain ◽  
Hira Choudhury ◽  
Nagashekhara Molugulu ◽  
Rajani B. Athawale ◽  
Prashant Kesharwani

Sudden outbreak of a new pathogen in numbers of pneumonic patients in Wuhan province during December 2019 has threatened the world population within a short period of its occurrence. This respiratory tract–isolated pathogen was initially named as novel coronavirus 2019 (nCoV-2019), but later termed as SARS-CoV-2. The rapid spreading of this infectious disease received the label of pandemic by the World Health Organization within 4 months of its occurrence, which still seeks continuous attention of the researchers to prevent the spread and for cure of the infected patients. The propagation of the disease has been recorded in 215 countries, with more than 25.5 million cases and a death toll of more than 0.85 million. Several measures are taken to control the disease transmission, and researchers are actively engaged in finding suitable therapeutics to effectively control the disease to minimize the mortality and morbidity rates. Several existing potential candidates were explored in the prevention and treatment of worsening condition of COVID-19 patients; however, none of the formulation has been approved for the treatment but used under medical supervision. In this article, a focus has been made to highlight on current epidemiology on the COVID-19 infection, clinical features, diagnosis, and transmission, with special emphasis on treatment measures of the disease at different stages of clinical research and the global economic influence due to this pandemic situation. Progress in the development on vaccine against COVID-19 has also been explored as important measures to immunize people. Moreover, this article is expected to provide information to the researchers, who are constantly combating in the management against this outbreak.


2021 ◽  
Vol 9 ◽  
Author(s):  
Uriel A. Angulo-Zamudio ◽  
Francisco M. Martínez-Villa ◽  
Nidia Leon-Sicairos ◽  
Hector Flores-Villaseñor ◽  
Jorge Velazquez-Roman ◽  
...  

The first cases of unexplained pneumonia were reported in Wuhan, China, in December of 2019. Later, a novel coronavirus (SARS-CoV-2) was identified as the causal agent of pneumonia. This virus has since spread to more than 180 countries and has been declared a pandemic by the World Health Organization. Herein, we aimed to determine the epidemiological and clinical characteristics of symptomatic patients with coronavirus disease 2019 (COVID-19) and the relationship between the influenza vaccine with a lower risk of severe COVID-19 infection in the state of Sinaloa. We collected demographic and clinical data of 4,040 patients with acute respiratory infections across Sinaloa state hospitals from February 28 to May 15, 2020. The prevalence of COVID-19 among hospitalized patients with respiratory symptoms in Sinaloa showed 45.2% of men were more affected than women (p < 0.001), and people aged 40–49 years were the most affected. The main symptoms of COVID-19 infection were cough and fever (p < 0.001), while hypertension, obesity, and type 2 diabetes were the chronic diseases associated with COVID-19 than non-COVID-19 (p < 0.003). Healthcare workers were most likely to be infected compared to other occupations (p < 0.001). The general lethality rate was 14.1%, and males >62 years were the ones who had a higher lethality rate (p < 0.001); the aforementioned chronic diseases were related to higher lethality of COVID-19 (p < 0.001). Likewise, higher lethality was seen in housewives and patient retirees/pensioners compared with other occupations (p < 0.001). Finally, we found there was a relationship between influenza vaccination and a lower risk of severe COVID-19 infection and mortality (p < 0.001). These findings showed that healthcare workers, men >62 years with chronic diseases, and retired people were most affected. Furthermore, the influenza vaccine could decrease the severeness of COVID-19 cases.


2020 ◽  
Author(s):  
Manoj Kumar Yadav ◽  
Arpana Vibhuti ◽  
Anjali Priyadarshini ◽  
Archana Gupta ◽  
V. Samuel Raj ◽  
...  

World Health Organization (WHO) announced the official name of the 2019 novel coronavirus associated diseases coronavirus disease (COVID-19) and the reference name for the virus is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Transmission of SARS CoV-2 in humans occurs mainly via respiratory droplet or aerosols, close contact with an infected person, exposed to coughing, sneezing and likely in oral-faecal. The COVID-19 outbreak started in different countries at different times, and now those countries are at different stages. By comparing infection trajectories from the 100th case mark, we have been able to observe the rapid spread of the virus in various countries. To date, no specific antiviral drugs or vaccines are available for the control of SARS CoV-2. The experts at global level suggest implementation of strict measures such as practicing quarantine, social distancing, avoiding social gathering to reduce the number of COVID-19 cases. This is a dynamically unfolding pandemic that will require the concerted efforts of counties around the world to control. Given the unfold of the new coronavirus and its impacts on human health, it becomes pertinent to device methods for handling this public health emergency at the community, national, and international levels. it's vital to additional investigate a preventative intervention to halt the unfold of the COVID-19 infection, because it has been discovered that not all countries have constant fate concerning infection and fatality. It becomes vital to acknowledge and study the factors accountable and also the underlying mechanisms for this.


2020 ◽  
Vol 6 (2) ◽  
pp. 40-42
Author(s):  
Tuba Tanveer ◽  

Viral pneumonia outbreak in Wuhan, China, in 2019 was observed and a novel coronavirus was identified as the cause of this outbreak. COVID-19 was the official term given by the World Health Organization and announced this on February 11, 2020 publicly. Corona virus spreads through person to person contact. The novel corona virus has taken a few months to sweep the globe, there are certain questions that are impossible to fathom as the disease rages. As the vaccine for Covid-19 is not yet discovered, the virus is being controlled from spreading worldwide through numerous strategies. Therefore, noticing the virulence of this virus several preventive measures have been taken at a global level to protect the human race. One of the effective measures in controlling the spread of respiratory disease epidemics is maintaining social distance and, therefore, can be used as a way to reduce its spread. Improving the immune power of a person is another crucial measure adopted to obviate its spread. AYUSH system of medicine is performing a central role in the contribution of meliorating the immune system of a person. Variety of herbal combinations have proven to perform the same function. The very first and easy way to boost the immunity and kill the virus, is to drink warm water throughout the day. It is further also advised to take steam once a day. 30 minutes of daily practice of Yogasana, Pranayama and meditation contributes in boosting immunity. Also using Dhaniya, Haldi, Jeera and Lahsun in cooking helps. It is also advised to use Half teaspoon Haldi with 150 ml of Hot milk, once or twice a day. Consuming Chyavanprash 10 mg in the morning is equally helpful.


Author(s):  
Masoumeh Rahmatinia ◽  
Anooshiravan Mohseni Bandpey ◽  
Abbas Shahsavani ◽  
Mostafa Hadei ◽  
Ahmad Jonidi Jafari ◽  
...  

Introduction: The novel coronavirus disease 2019, namely COVID-19, has been known as a global pandemic by the World Health Organization (WHO). To prevent of COVID-19 spread, most countries including Iran have implemented many preventive measures. This study aimed to evaluate the effect of implementation (Phase-01)/non- implementation (Phase-02) of the traffic plan on confirmed cases, suspected cases, and mortality cases by COVID-19 as well as on air quality in Tehran. Materials and methods: Daily data of confirmed COVID-19 cases, suspected COVID-19 cases, mortality COVID-19 cases, air pollutants concentration and meteorological variables were obtained from 26 February, 2020 to 5August, 2020 in Tehran megacity and data were compared during the period’s implementation /non-implementation of traffic plan in Tehran. Results: Our results showed that the non-implementation of traffic plan has been effective in reducing the number of daily confirmed cases, suspected cases and mortality by COVID-19. Also, the average concentration of PM10, PM2.5, NO2 , O3 , SO2 and CO have reduced significantly during nonimplementation traffic plan phase. Conclusion: Our findings indicate that there is a significant association between non-implementation traffic plan and reduce risk of COVID-19 infection.


2020 ◽  
Vol 17 (01) ◽  
Author(s):  
Ans Irfan ◽  
Ankita Arora ◽  
Christopher Jackson ◽  
Celina Valencia

World Health Organization (WHO) estimates indicate the United States of America has the highest novel Coronavirus disease (COVID-19) burden in the world, with over 5 million confirmed cases and nearly 165,000 associated deaths as of August 14th, 2020 (WHO 2020). As the COVID-19 mortality and morbidity has disproportionately impacted populations who experience vulnerabilities due to structural issues such as racism (Laurencin and McClinton 2020; Lin II and Money 2020; Martin 2020; Kim et al. 2020), it has become increasingly necessary to take this opportunity and intentionally codify diversity, equity, and inclusion (DEI) practices in the policymaking process. To encourage and facilitate this, we synthesize existing literature to identify best practices that can not only be used to inform COVID-19-related public policy activities but will also continue to inform inclusive policymaking processes in the future. We identify specific tools for policymakers at all levels of government to better operationalize the DEI framework and enact inclusive, equitable public policies as a result.


Author(s):  
Henrique Damasceno Vianna ◽  
Fábio Pittoli ◽  
Emerson Butzen Marques ◽  
Jorge Luis Victoria Barbosa

According to World Health Organization, the treatment of non-communicable diseases needs more than patient engagement to help control the diseases. Community and health organizations support is also desirable for controlling them. This work details the UDuctor middleware, which was designed for supporting ubiquitous non-communicable disease care, and so, helping the integration between patient and community resources. The UDuctor middleware gives a step forward in relation to other architectures for ubiquitous applications by integrating patients, community resources and community members through a peer-to-peer network. Each peer runs a RESTFul based middleware, which enables messaging, resource sharing, context subscription and notification, and location between other UDuctor peers. The middleware implementation was employed in two solutions and tested in three experiments. The results are promising and show feasibility for the application of the middleware in real life situations.


Author(s):  
Ronald Labonté ◽  
Arne Ruckert

Notwithstanding the threat of infectious pandemics, non-communicable diseases (NCDs) are now the leading cause of preventable mortality and morbidity in all regions of the world except Africa. The rise in NCDs, especially in the developing world, is very much a result of global market integration, trade and investment liberalization, and the growth in the reach and power of transnational corporations whose stock-in-trade are health-harmful commodities (tobacco, alcohol, and obesogenic foods). The modern global governance challenge of what are now referred to as the ‘commercial determinants of health’ is the extent to which such commodities are regulated by governments, passed over to corporate social (self-) responsibility, or seen as an amalgam of the poor lifestyles of individuals in need of a behavioural ‘nudge’. The World Health Organization, the lead international organization developing responses to the NCD threat, must confront powerful member nations representing powerful corporate interests resistant to regulatory change.


2020 ◽  
Vol 13 (4) ◽  
pp. 1791-1807
Author(s):  
Deepika Purohit ◽  
Manisha Saini ◽  
Nisha Pathak ◽  
Ravinder Verma ◽  
Deepak Kaushik ◽  
...  

A novel threat to mankind by novel coronavirus infection occurred in December 2019. According to the World Health Organization (WHO) Situation Report-141, 7,039,918 confirmed cases and 404,396 death cases were observed till 9 June 2020 in the different regions of world. Therefore, this article aims to summarize and share the update on the present status of the outbreak and possible treatment options. The present review focuses on latest statistics, diagnostic and preventive measures under study and the future planning of the researchers to discover an effective cure for this threat to the mankind. For carrying out this review, literature searches were performed on Clinicaltrials.gov, official website of WHO, Centers for Disease Control and Prevention, PubMed, Google scholars, etc. Data from these searches was collected and evaluated for getting the available literature on COVID-19 outbreak and drugs under study. The details of history, virology, epidemiology, possible therapeutic options, associated risk factors and preventive measures related to COVID-19 are compiled here in this review. Along with this, some ongoing clinical trials have also been included in this review in order to conclude the efforts of researchers towards controlling this outbreak. The trajectory and severity of this outbreak can’t be predicted at present, but immediate actions are required to be taken in order to develop and implement an effective treatment against the global threat.


Sign in / Sign up

Export Citation Format

Share Document